10-Q 1 eye-20220402.htm 10-Q eye-20220402
0001710155December 312022Q1falseP9MP1YP1YP1YP5Y00017101552022-01-022022-04-0200017101552022-04-29xbrli:shares00017101552022-04-02iso4217:USD00017101552022-01-01iso4217:USDxbrli:shares0001710155eye:ProductSalesMember2022-01-022022-04-020001710155eye:ProductSalesMember2021-01-032021-04-030001710155eye:ServicesAndPlansMember2022-01-022022-04-020001710155eye:ServicesAndPlansMember2021-01-032021-04-0300017101552021-01-032021-04-030001710155us-gaap:CommonStockMember2022-01-010001710155us-gaap:AdditionalPaidInCapitalMember2022-01-010001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-010001710155us-gaap:RetainedEarningsMember2022-01-010001710155us-gaap:TreasuryStockMember2022-01-010001710155us-gaap:CommonStockMember2022-01-022022-04-020001710155us-gaap:AdditionalPaidInCapitalMember2022-01-022022-04-020001710155us-gaap:TreasuryStockMember2022-01-022022-04-020001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-022022-04-020001710155us-gaap:RetainedEarningsMember2022-01-022022-04-020001710155us-gaap:CommonStockMember2022-04-020001710155us-gaap:AdditionalPaidInCapitalMember2022-04-020001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-020001710155us-gaap:RetainedEarningsMember2022-04-020001710155us-gaap:TreasuryStockMember2022-04-020001710155us-gaap:CommonStockMember2021-01-020001710155us-gaap:AdditionalPaidInCapitalMember2021-01-020001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-020001710155us-gaap:RetainedEarningsMember2021-01-020001710155us-gaap:TreasuryStockMember2021-01-0200017101552021-01-020001710155us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-020001710155us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-020001710155us-gaap:CommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AdditionalPaidInCapitalMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:RetainedEarningsMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:TreasuryStockMember2021-01-020001710155srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-01-020001710155us-gaap:CommonStockMember2021-01-032021-04-030001710155us-gaap:AdditionalPaidInCapitalMember2021-01-032021-04-030001710155us-gaap:TreasuryStockMember2021-01-032021-04-030001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-032021-04-030001710155us-gaap:RetainedEarningsMember2021-01-032021-04-030001710155us-gaap:CommonStockMember2021-04-030001710155us-gaap:AdditionalPaidInCapitalMember2021-04-030001710155us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-030001710155us-gaap:RetainedEarningsMember2021-04-030001710155us-gaap:TreasuryStockMember2021-04-0300017101552021-04-03eye:storeeye:storeBrand0001710155us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-04-02eye:day0001710155us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-01xbrli:pure0001710155us-gaap:TradeAccountsReceivableMember2022-04-020001710155us-gaap:TradeAccountsReceivableMember2022-01-010001710155us-gaap:CreditCardReceivablesMember2022-04-020001710155us-gaap:CreditCardReceivablesMember2022-01-010001710155eye:OtherReceivablesMember2022-04-020001710155eye:OtherReceivablesMember2022-01-010001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMember2022-04-020001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2022-04-020001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2022-01-010001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMember2022-01-010001710155us-gaap:LoansPayableMembereye:FirstLienTermALoanDueJuly182024Member2022-04-020001710155us-gaap:LoansPayableMembereye:FirstLienTermALoanDueJuly182024Member2022-01-010001710155us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-04-020001710155us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-01-010001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMember2022-01-022022-04-020001710155eye:ConvertibleSeniorNotesDueIn2025Memberus-gaap:ConvertibleDebtMember2021-01-032021-04-030001710155eye:InterestRateCollarMember2022-04-020001710155us-gaap:NondesignatedMembereye:InterestRateCollarMember2022-04-020001710155us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMembereye:InterestRateCollarMember2022-04-020001710155us-gaap:NondesignatedMemberus-gaap:OtherAssetsMembereye:InterestRateCollarMember2022-04-020001710155us-gaap:NondesignatedMembereye:InterestRateCollarMember2022-01-010001710155us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMembereye:InterestRateCollarMember2022-01-010001710155us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMembereye:InterestRateCollarMember2022-01-010001710155eye:InterestRateCollarMember2022-01-022022-04-020001710155eye:InterestRateCollarMember2021-01-032021-04-030001710155us-gaap:PerformanceSharesMember2022-01-022022-04-020001710155us-gaap:RestrictedStockUnitsRSUMember2022-01-022022-04-02eye:installment0001710155srt:MinimumMember2022-01-022022-04-020001710155srt:MaximumMember2022-01-022022-04-020001710155us-gaap:TransferredAtPointInTimeMember2022-01-022022-04-020001710155us-gaap:TransferredAtPointInTimeMember2021-01-032021-04-030001710155us-gaap:TransferredOverTimeMember2022-01-022022-04-020001710155us-gaap:TransferredOverTimeMember2021-01-032021-04-0300017101552022-04-032022-04-0200017101552023-01-012022-04-0200017101552023-12-312022-04-0200017101552024-12-292022-04-0200017101552026-01-042022-04-020001710155srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2022-01-022022-04-020001710155us-gaap:BuildingAndBuildingImprovementsMembersrt:MaximumMember2022-01-022022-04-02eye:segment0001710155eye:ProductSalesMembereye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155eye:LegacyMembereye:ProductSalesMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155eye:ProductSalesMemberus-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2022-01-022022-04-020001710155us-gaap:MaterialReconcilingItemsMembereye:ProductSalesMember2022-01-022022-04-020001710155eye:ServicesAndPlansMembereye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155eye:LegacyMembereye:ServicesAndPlansMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155eye:ServicesAndPlansMemberus-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2022-01-022022-04-020001710155us-gaap:MaterialReconcilingItemsMembereye:ServicesAndPlansMember2022-01-022022-04-020001710155eye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155eye:LegacyMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001710155us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2022-01-022022-04-020001710155us-gaap:MaterialReconcilingItemsMember2022-01-022022-04-020001710155eye:ProductSalesMembereye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155eye:LegacyMembereye:ProductSalesMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155eye:ProductSalesMemberus-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2021-01-032021-04-030001710155us-gaap:MaterialReconcilingItemsMembereye:ProductSalesMember2021-01-032021-04-030001710155eye:ServicesAndPlansMembereye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155eye:LegacyMembereye:ServicesAndPlansMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155eye:ServicesAndPlansMemberus-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2021-01-032021-04-030001710155us-gaap:MaterialReconcilingItemsMembereye:ServicesAndPlansMember2021-01-032021-04-030001710155eye:OwnedAndHostStoreBrandsMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155eye:LegacyMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001710155us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2021-01-032021-04-030001710155us-gaap:MaterialReconcilingItemsMember2021-01-032021-04-030001710155eye:StockOptionsAndRestrictedStockUnitsRSUsMember2022-01-022022-04-020001710155eye:StockOptionsAndRestrictedStockUnitsRSUsMember2021-01-032021-04-030001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-010001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-020001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-022022-04-020001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-032021-04-030001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-020001710155us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________
FORM 10-Q
_______________________________________________________________________
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 2, 2022
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from           to         
Commission file number 001-38257
_______________________________________________________________________
National Vision Holdings, Inc.
(Exact name of registrant as specified in its charter)
_______________________________________________________________________
Delaware 46-4841717
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2435 Commerce Ave 
Building 220030096
Duluth, Georgia
(Zip Code)
(Address of principal executive offices)
(770822‑3600
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
_______________________________________________________________________
Securities registered pursuant to Section 12(b) of the Act
Title of each class Trading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareEYENASDAQ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes    No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No  
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class Outstanding at April 29, 2022
Common stock, $0.01 par value 81,421,901



NATIONAL VISION HOLDINGS, INC. AND SUBSIDIARIES


Table of Contents
Page




SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the “safe harbor” created by those sections. All statements, other than statements of historical facts included in this Form 10-Q, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, business trends and other information, may be forward-looking statements.
Words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” and variations of such words or similar expressions are intended to identify forward-looking statements. The forward-looking statements are not historical facts or guarantees of future performance and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this Form 10-Q. Such risks, uncertainties and other important factors that could cause actual results to differ include, among others, the risks, uncertainties and factors set forth in Part II, Item 1A - “Risk Factors” in this Form 10-Q and Part I, Item 1A - “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended January 1, 2022 (the “2021 Annual Report on Form 10-K”), as filed with the Securities and Exchange Commission (the “SEC”), as such risk factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov, and also include the following:
the COVID-19 pandemic and its resurgence and variants, and the impact of evolving federal, state, and local governmental actions in response thereto, including risks stemming from vaccination and testing programs and mandates;
customer behavior in response to the continuing pandemic and its more recent outbreaks of variants, including the impact of such behavior on in-store traffic and sales;
overall decline in the health of the economy and other factors impacting consumer spending, including inflation and geopolitical instability;
our ability to open and operate new stores in a timely and cost-effective manner, or keep stores safely open in light of the continuing COVID-19 pandemic, and to successfully enter new markets;
our ability to recruit and retain vision care professionals for our stores in general and in light of the pandemic;
our ability to develop, maintain and extend relationships with managed vision care companies, vision insurance providers and other third-party payors;
our ability to maintain the performance of our Host and Legacy brands and our current operating relationships with our Host and Legacy partners;
our ability to adhere to extensive state, local and federal vision care and healthcare laws and regulations;
our compliance with managed vision care laws and regulations;
our ability to maintain sufficient levels of cash flow from our operations to execute or sustain our growth strategy or obtain additional financing at satisfactory terms or at all;
the loss of, or disruption in the operations of, one or more of our distribution centers and/or optical laboratories, resulting in the inability to fulfill customer orders and deliver our products in a timely manner;
risks associated with vendors from whom our products are sourced, including our dependence on a limited number of suppliers;
our ability to compete successfully;
our ability to effectively operate our information technology systems and prevent interruption or security breach;
the impact of wage rate increases, inflation, cost increases and increases in raw material prices and energy prices;
our growth strategy straining our existing resources and causing the performance of our existing stores to suffer;
our ability to successfully and efficiently implement our marketing, advertising and promotional efforts;
risks associated with leasing substantial amounts of space, including future increases in occupancy costs;
the impact of certain technological advances, and the greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems;
our ability to retain our existing senior management team and attract qualified new personnel;
3

our ability to manage our inventory;
seasonal fluctuations in our operating results and inventory levels;
our reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of our revenues;
risks associated with our e-commerce and omni-channel business;
product liability, product recall or personal injury issues;
our failure to comply with, or changes in, laws, regulations, enforcement activities and other requirements;
the impact of any adverse litigation judgments or settlements resulting from legal proceedings relating to our business operations;
risk of losses arising from our investments in technological innovators in the optical retail industry;
our ability to adequately protect our intellectual property;
risks associated with environmental, social and governance issues, including climate change;
our significant amount of indebtedness and our ability to generate sufficient cash flow to satisfy our debt obligations;
a change in interest rates as well as changes in benchmark rates and uncertainty related to the foregoing;
restrictions in our credit agreement that limits our flexibility in operating our business;
potential dilution to existing stockholders upon the conversion of our convertible notes; and
risks related to owning our common stock, including our ability to comply with requirements to design and implement and maintain effective internal controls.
We caution you that the risks, uncertainties and other factors referenced above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this Form 10-Q apply only as of the date of this Form 10-Q or as of the date they were made and, except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
All references to “we,” “us,” “our,” or the “Company” in this Form 10-Q mean National Vision Holdings, Inc. and its subsidiaries, unless the context otherwise requires. References to “eye care practitioners” in this Form 10-Q mean optometrists and ophthalmologists and references to “vision care professionals” mean optometrists (including optometrists employed by us or by professional corporations owned by eye care practitioners with which we have arrangements) and opticians.
Website Disclosure
We use our website www.nationalvision.com as a channel of distribution of Company information. Financial and other important information regarding the Company is routinely accessible through and posted on our website. Accordingly, investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about National Vision Holdings, Inc. when you enroll your e-mail address by visiting the “Email Alerts” page of the Investor Resources section of our website at www.nationalvision.com/investors. The contents of our website are not, however, a part of this Form 10-Q.
4

PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements (Unaudited)

National Vision Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
As of April 2, 2022 and January 1, 2022
In Thousands, Except Par Value
(Unaudited)
As of
April 2, 2022
As of
January 1, 2022
ASSETS
Current assets:
Cash and cash equivalents$314,642 $305,800 
Accounts receivable, net62,245 55,697 
Inventories127,401 123,669 
Prepaid expenses and other current assets28,306 29,410 
Total current assets532,594 514,576 
Noncurrent assets:
Property and equipment, net350,412 346,436 
Goodwill777,613 777,613 
Trademarks and trade names240,547 240,547 
Other intangible assets, net40,147 42,020 
Right of use assets361,908 354,900 
Other assets22,266 16,999 
Total non-current assets1,792,893 1,778,515 
Total assets$2,325,487 $2,293,091 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$69,414 $64,331 
Other payables and accrued expenses91,865 119,323 
Unearned revenue43,632 29,895 
Deferred revenue65,225 65,325 
Current maturities of long-term debt and finance lease obligations4,704 3,999 
Current operating lease obligations70,567 60,930 
Total current liabilities345,407 343,803 
Noncurrent liabilities:
Long-term debt and finance lease obligations, less current portion and debt discount564,655 566,081 
Non-current operating lease obligations340,902 342,241 
Deferred revenue23,343 23,166 
Other liabilities9,133 8,974 
Deferred income taxes, net91,321 82,846 
Total non-current liabilities1,029,354 1,023,308 
Commitments and contingencies (See Note 9)
Stockholders’ equity:
Common stock, $0.01 par value; 200,000 shares authorized; 84,129 and 83,840 shares issued as of April 2, 2022 and January 1, 2022, respectively; 81,422 and 81,405 shares outstanding as of April 2, 2022 and January 1, 2022, respectively
841 838 
Additional paid-in capital755,535 750,478 
Accumulated other comprehensive loss(1,752)(1,940)
Retained earnings308,542 278,395 
Treasury stock, at cost; 2,707 and 2,435 shares as of April 2, 2022 and January 1, 2022, respectively
(112,440)(101,791)
Total stockholders’ equity950,726 925,980 
Total liabilities and stockholders’ equity$2,325,487 $2,293,091 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

National Vision Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income
For the Three Months Ended April 2, 2022 and April 3, 2021
In Thousands, Except Earnings Per Share
(Unaudited)
Three Months Ended
April 2, 2022April 3, 2021
Revenue:
Net product sales$433,253 $443,067 
Net sales of services and plans 94,458 91,113 
Total net revenue527,711 534,180 
Costs applicable to revenue (exclusive of depreciation and amortization):
Products164,219 159,691 
Services and plans71,818 64,999 
Total costs applicable to revenue236,037 224,690 
Operating expenses:
Selling, general and administrative expenses228,554 223,593 
Depreciation and amortization25,151 23,555 
Asset impairment406 959 
Other expense (income), net231 (65)
Total operating expenses 254,342 248,042 
Income from operations37,332 61,448 
Interest expense (income), net(4,144)6,330 
Earnings before income taxes41,476 55,118 
Income tax provision11,329 11,686 
Net income$30,147 $43,432 
Earnings per share:
Basic$0.37 $0.53 
Diluted$0.34 $0.48 
Weighted average shares outstanding:
Basic81,428 81,333 
Diluted94,904 96,025 
Comprehensive income:
Net income$30,147 $43,432 
Unrealized gain on hedge instruments252 1,650 
Tax provision of unrealized gain on hedge instruments64 2,546 
Comprehensive income $30,335 $42,536 
The accompanying notes are an integral part of these condensed consolidated financial statements.
6


National Vision Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ Equity
For the Three Months Ended April 2, 2022 and April 3, 2021
In Thousands
(Unaudited)
Three Months Ended April 2, 2022
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Loss
Retained EarningsTreasury
Stock
Total
Stockholders’
Equity
SharesAmount
Balances at January 1, 202281,405 $838 $750,478 $(1,940)$278,395 $(101,791)$925,980 
Issuance of common stock289 3 1,366 — — — 1,369 
Stock based compensation— — 3,692 — — — 3,692 
Purchase of treasury stock(272)— — — — (10,649)(10,649)
Settlement of 2025 Notes— — (1)— — — (1)
Unrealized gain (loss) on hedge instruments, net of tax— — — 188 — — 188 
Net income— — — — 30,147 — 30,147 
Balances at April 2, 202281,422 $841 $755,535 $(1,752)$308,542 $(112,440)$950,726 

Three Months Ended April 3, 2021
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Loss
Retained EarningsTreasury
Stock
Total
Stockholders’
Equity
SharesAmount
Balances at January 2, 202181,239 $821 $795,697 $(4,400)$142,880 $(28,496)$906,502 
Cumulative effect of change in accounting principle — — (71,385)— 7,271 — (64,114)
Balances at January 3, 2021 - as adjusted81,239 821 724,312 (4,400)150,151 (28,496)842,388 
Issuance of common stock174 2 1,056 — — — 1,058 
Stock based compensation— — 2,971 — — — 2,971 
Purchase of treasury stock(28)— — — — (1,421)(1,421)
Unrealized gain (loss) on hedge instruments, net of tax— — — (896)— — (896)
Net income— — — — 43,432 — 43,432 
Balances at April 3, 202181,385 $823 $728,339 $(5,296)$193,583 $(29,917)$887,532 
The accompanying notes are an integral part of these condensed consolidated financial statements.
7

National Vision Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
For the Three Months Ended April 2, 2022 and April 3, 2021
In Thousands
(Unaudited)
Three Months Ended
April 2, 2022April 3, 2021
Cash flows from operating activities:
Net income$30,147 $43,432 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization25,151 23,555 
Amortization of debt discount and deferred financing costs770 762 
Asset impairment 406 959 
Deferred income tax expense 8,410 11,686 
Stock based compensation expense3,734 2,988 
Losses (gains) on change in fair value of derivatives(9,727)(2,252)
Inventory adjustments838 177 
Other1,227 594 
Changes in operating assets and liabilities:
Accounts receivable(6,620)(2,698)
Inventories(4,570)(8,428)
Operating lease right of use assets and lease liabilities365 (484)
Other assets1,875 (235)
Accounts payable5,083 14,946 
Deferred and unearned revenue13,814 22,973 
Other liabilities(23,786)(10,323)
Net cash provided by operating activities47,117 97,652 
Cash flows from investing activities:
Purchase of property and equipment(28,097)(16,382)
Other20 8 
Net cash used for investing activities(28,077)(16,374)
Cash flows from financing activities:
Repayments on long-term debt(3) 
Proceeds from issuance of common stock1,820 1,868 
Purchase of treasury stock(10,649)(1,421)
Payments on finance lease obligations(1,109)(1,536)
Net cash used for financing activities(9,941)(1,089)
Net change in cash, cash equivalents and restricted cash9,099 80,189 
Cash, cash equivalents and restricted cash, beginning of year306,876 375,159 
Cash, cash equivalents and restricted cash, end of period$315,975 $455,348 
Supplemental cash flow disclosure information:
Cash paid for interest$2,322 $5,706 
Cash paid (received) for taxes$(127)$365 
Capital expenditures accrued at the end of the period$10,129 $9,247 
    
The accompanying notes are an integral part of these condensed consolidated financial statements.
8



National Vision Holdings, Inc. and Subsidiaries
Index to Notes to Condensed Consolidated Financial Statements


9

National Vision Holdings, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements (Unaudited)


1. Description of Business and Basis of Presentation
Nature of Operations
National Vision Holdings, Inc. (“NVHI,” the “Company,” “we,” “our,” or “us”) is a holding company whose operating subsidiaries include its indirect wholly-owned subsidiary, National Vision, Inc. (“NVI”) and NVI’s wholly-owned subsidiaries. We are a leading value retailer of eyeglasses and contact lenses in the United States. We operated 1,292 and 1,278 retail optical locations in the United States and its territories as of April 2, 2022 and January 1, 2022, respectively, through our five store brands, including America’s Best Contacts and Eyeglasses (“America’s Best”), Eyeglass World, Vista Optical locations on select U.S. Army/Air Force military bases (“Military”) and within select Fred Meyer stores, and our management & services arrangement with Walmart (“Legacy”).
Basis of Presentation and Principles of Consolidation
We prepare our unaudited interim condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and, therefore, do not include all information and disclosures required by U.S. GAAP for complete consolidated financial statements. The condensed consolidated balance sheet as of January 1, 2022 has been derived from the audited consolidated balance sheet for the fiscal year then ended. These condensed consolidated financial statements reflect all normal and recurring adjustments which are, in the opinion of management, necessary to present fairly the Company’s consolidated results of the interim period.
Certain information and disclosures normally included in our annual consolidated financial statements have been condensed or omitted; however, we believe that the disclosures included herein are sufficient for a fair presentation of the information presented. These condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the fiscal year ended January 1, 2022 included in the 2021 Annual Report on Form 10-K. The Company’s significant accounting policies are set forth in Note 1 within those consolidated financial statements. We use the same accounting policies in preparing interim condensed consolidated financial information and annual consolidated financial statements. There were no changes to our significant accounting policies during the three months ended April 2, 2022.
The condensed consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain amounts within the Consolidated Statements of Operations and footnotes to the financial statements for fiscal year 2021 have been reclassified to conform to the fiscal year 2022 presentation.
The Company has consolidated certain entities meeting the definition of a variable interest entity (“VIE”) as the Company concluded that it is the primary beneficiary of the entities under the provisions of Accounting Standards Codification 810, Consolidation. At April 2, 2022, the variable interest entities include 31 professional corporations. The total assets of the consolidated VIEs included in the accompanying Consolidated Balance Sheets as of April 2, 2022 and January 1, 2022, were $3.0 million and $6.0 million, respectively, and the total liabilities of the consolidated VIEs were $3.5 million and $6.8 million, respectively.
Fiscal Year
Our fiscal year consists of 52 or 53 weeks ending on the Saturday closest to December 31. Fiscal year 2022 contains 52 weeks and will end on December 31, 2022. All three month periods presented herein contain 13 weeks, respectively. All references to years and quarters relate to fiscal periods rather than calendar periods.
10

Seasonality
The consolidated results of operations for the three months ended April 2, 2022 and April 3, 2021, are not necessarily indicative of the results to be expected for the full fiscal year due to seasonality and uncertainty of general economic conditions that may impact our key end markets. Historically, our business has realized a higher portion of net revenue, income from operations, and cash flows from operations in the first half of the year, and a lower portion of net revenue, income from operations, and cash flows from operations in the fourth fiscal quarter. The first half seasonality is attributable primarily to the timing of our customers’ personal income tax refunds and annual health insurance program start/reset periods, although delays in tax refund timing occurred in 2020 and 2021, and may continue in future years. Seasonality related to fourth quarter holiday spending by retail customers generally does not impact our business. Our quarterly consolidated results generally may also be affected by the timing of new store openings, store closings, and certain holidays.
Since the start of the COVID-19 pandemic and the resulting temporary closure of our stores to the public for a portion of the first half of fiscal year 2020, there have been changes in our historic seasonality in fiscal year 2020 and 2021. We expect that COVID-19 will continue to cause changes to the seasonality we have historically experienced in fiscal year 2022 and beyond.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Income Taxes
Our effective tax rates for the three months ended April 2, 2022 and April 3, 2021 were 27.3% and 21.2%, respectively, reflecting our statutory federal and state rate of 25.5% and effects of other permanent items as well as a stranded tax effect of $2.1 million associated with our matured interest rate swaps during the three months ended April 3, 2021.
Share Repurchases
During the three months ended April 2, 2022, the Company repurchased 0.2 million shares of its common stock for $7.1 million under the share repurchase program. After these repurchases, $123.0 million remains available under the share repurchase authorization.
Future Adoption of Accounting Pronouncements
Reference Rate Reform. In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that may be affected by the cessation of the London Inter-bank Offered Rate (“LIBOR.”) An entity may elect to apply the amendments for contract modifications as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2022. A portion of our debt is subject to interest payments that are indexed to LIBOR; additionally, we are party to an interest rate derivative based on LIBOR. We are currently evaluating the effect of this guidance and have not applied the provisions of this guidance during the current fiscal year.
The FASB issued other accounting guidance during the period that is not currently applicable or expected to have a material impact on the Company’s condensed consolidated financial statements, and therefore, is not described above.

11

2. Details of Certain Balance Sheet Accounts
The following table provides a reconciliation of cash and cash equivalents reported within the Condensed Consolidated Balance sheets to the total of Cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statement of Cash Flows:
Three Months Ended
In thousandsApril 2, 2022April 3, 2021
Cash, cash equivalents and restricted cash:
Cash and cash equivalents$314,642 $453,792 
Restricted cash included in other assets1,333 1,556 
$315,975 $455,348 

The following tables provide additional details of certain balance sheet accounts as of the dates shown below:

In thousandsAs of
April 2, 2022
As of
January 1, 2022
Accounts receivable, net:
Trade receivables$36,410 $32,504 
Credit card receivables20,608 17,010 
Other receivables5,658 6,685 
Allowance for credit losses(431)(502)
$62,245 $55,697 
In thousandsAs of
April 2, 2022
As of
January 1, 2022
Inventories:
Raw materials and work in process (1)
$62,620 $65,262 
Finished goods64,781 58,407 
$127,401 $123,669 
(1)Due to the immaterial amount of estimated work in process and the short lead times for the conversion of raw materials to finished goods, the Company does not separately present raw materials and work in process.
In thousandsAs of
April 2, 2022
As of
January 1, 2022
Other payables and accrued expenses:
Associate compensation and benefits$29,685 $55,670 
Self-insurance liabilities9,041 9,034 
Capital expenditures10,129 10,571 
Advertising6,947 6,962 
Reserves for customer returns and remakes9,320 7,556 
Legacy management & services agreement5,401 5,518 
Fair value of derivative liabilities 2,846 
Supplies and other store support expenses3,918 5,511 
Litigation settlements572 2,100 
Lease concessions345 357 
Other16,507 13,198 
$91,865 $119,323 
12

In thousandsAs of
April 2, 2022
As of
January 1, 2022
Other non-current liabilities:
Fair value of derivative liabilities$ $488 
Self-insurance liabilities6,376 6,170 
Other2,757 2,316 
$9,133 $8,974 


3. Fair Value Measurement

Recurring fair value measurements
Interest Rate Derivatives
We recognize as assets or liabilities at fair value the estimated amounts we would receive or pay upon a termination of interest rate derivatives prior to their scheduled expiration dates. The fair value is based on information that is model-driven and whose inputs were observable (Level 2 inputs) such as LIBOR forward rates. See Note 5. “Interest Rate Derivatives” for further details.
Non-recurring fair value measurements
Tangible Long-lived and Right of Use (“ROU”) Store Assets
We recognized impairments of $0.4 million and $1.0 million during the three months ended April 2, 2022 and April 3, 2021, respectively, related to our long-lived tangible store assets and ROU assets. The impairments were primarily driven by lower than projected customer sales volume in certain stores. The cash flows used in estimating fair value were discounted using a market rate of 7.5%. A decrease in the estimated cash flows would lead to a lower fair value measurement, as would an increase in the discount rate. These non-recurring fair value measurements are classified as Level 3 measurements in the fair value hierarchy. The estimated remaining fair value of the assets impaired during the three months ended April 2, 2022 and April 3, 2021 was $2.0 million and $2.0 million, respectively. Substantially all of the remaining fair value of the impaired store assets represents the fair value of ROU assets.
Additional fair value information
Long-term Debt - 2025 Notes
The Company has $402.5 million in aggregate principal amount of 2.50% convertible senior notes due on May 15, 2025 (the “2025 Notes”) issued and outstanding as of April 2, 2022. Refer to Note 4. “Long-term Debt” for more information on the 2025 Notes. The estimated fair value of the 2025 Notes was approximately $629.6 million and $674.9 million as of April 2, 2022 and January 1, 2022, respectively. The estimated fair value of the 2025 Notes is based on the prices the 2025 Notes have traded in the market, as well as overall market conditions on the date of valuation, stated coupon rates, the number of coupon payments each year and the maturity dates, and represents a Level 2 measurement in the fair value hierarchy. Refer to Note 4. “Long-term Debt” for more information on the 2025 Notes.

13

4. Long-term Debt

Long-term debt consists of the following:
In thousandsAs of
April 2, 2022
As of
January 1, 2022
2025 Notes, due May 15, 2025$402,498 $402,500 
Term loan, due July 18, 2024150,000 150,000 
Revolving credit facility, due July 18, 2024  
Long-term debt before debt discount552,498 552,500 
Unamortized discount and issuance costs - 2025 Notes(7,465)(7,986)
Unamortized discount and issuance costs - term loan(855)(948)
Long-term debt less debt discount544,178 543,566 
Less current maturities  
Long-term debt - non-current portion544,178 543,566 
Finance lease obligations25,181 26,514 
Less current maturities(4,704)(3,999)
Long-term debt and finance lease obligations, less current portion and debt discount$564,655 $566,081 
Credit Agreement
We were in compliance with all covenants related to our long-term debt as of April 2, 2022.
2025 Notes
We recognized $2.5 million and $0.5 million in interest expense for the interest coupon and amortization of issuance costs, respectively, during the three months ended April 2, 2022 and $2.5 million and $0.5 million, respectively during the three months ended April 3, 2021. As of April 2, 2022, the remaining period for the unamortized debt issuance costs balance was approximately three years. An immaterial amount of the principal balance of the 2025 Notes was converted during the three months ended April 2, 2022.
As of April 2, 2022, the stock price conditions under which the 2025 Notes can be converted at the holders’ option were not met.

5. Interest Rate Derivatives
We are party to an interest rate collar to offset the variability of cash flows in LIBOR-indexed debt interest payments. To manage credit risk associated with our interest rate hedging program, we select as counterparties major financial institutions with investment grade credit ratings. The aggregate notional amount of the interest rate collar, which is not designated as a cash flow hedge, was $350.0 million as of April 2, 2022. The fair value of our interest rate collar instrument was an asset of $6.6 million ($1.0 million in Prepaid expenses and other current assets and $5.6 million in Other assets) as of April 2, 2022, and a liability of $3.3 million ($2.8 million in Other payables and accrued expenses and $0.5 million in Other non-current liabilities) as of January 1, 2022, respectively. See Note 3. “Fair Value Measurement” for further details.
Gains (losses) on the change in fair value of the interest rate collar of $9.0 million and $2.0 million were recorded in interest expense (income), net during the three months ended April 2, 2022 and April 3, 2021, respectively. We recognized $1.5 million in interest expense (income), net during the three months ended April 3, 2021 related to our interest rate swaps that were considered to be highly effective hedges and that matured during the three months ended April 3, 2021.
Cash flows related to derivatives qualifying as hedges are included in the same section of the Condensed Consolidated Statements of Cash Flows as the underlying assets and liabilities being hedged. Cash flows during the three months ended April 2, 2022 and April 3, 2021 related to derivatives not qualifying as hedges were included in the operating section of the Condensed Consolidated Statements of Cash Flows and were immaterial. As of April 2, 2022 we expect to reclassify approximately $0.8 million of unrealized losses on derivative instruments, net of tax, from Accumulated other comprehensive loss (“AOCL”) into earnings in the next 12 months as the derivative instruments mature. See Note 12. “Accumulated Other Comprehensive Loss” for further details.
14


6. Stock Incentive Plans
During the three months ended April 2, 2022, the Company granted 153,494 performance-based restricted stock units (“PSUs”) and 245,466 time-based restricted stock units (“RSUs”) to eligible employees under the National Vision Holdings, Inc. 2017 Omnibus Incentive Plan (the “2017 Omnibus Incentive Plan”). The PSUs granted in fiscal 2022 are settled after the end of the performance period (i.e., cliff vesting), which begins on the first day of our 2022 fiscal year and ends on the last day of our 2024 fiscal year, and are based on the Company’s achievement of certain performance targets. The RSUs granted in fiscal 2022 vest primarily in three equal installments.

7. Revenue From Contracts With Customers
The majority of our revenues are recognized either at the point of sale or upon delivery and customer acceptance, paid for at the time of sale in cash, credit card, or on account with managed care payors having terms generally between 14 and 120 days, with most paying within 90 days. For sales of in-store non-prescription eyewear and related accessories, and paid eye exams, we recognize revenue at the point of sale. Our point in time revenues include 1) retail sales of prescription and non-prescription eyewear, contact lenses and related accessories to retail customers (including those covered by managed care), 2) eye exams and 3) wholesale sales of inventory in which our customer is another retail entity. Revenues recognized over time primarily include product protection plans (i.e. warranties), eye care club memberships and management fees earned from our Legacy partner.
The following disaggregation of revenues depicts our revenue based on the timing of revenue recognition:
Three Months Ended
In thousandsApril 2, 2022April 3, 2021
Revenues recognized at a point in time$485,085 $493,438 
Revenues recognized over time42,626 40,742 
Total net revenue $527,711 $534,180 
Refer to Note 10. “Segment Reporting” for the Company’s disaggregation of net revenue by reportable segment. As the reportable segments are aligned by similar economic factors, trends and customers, the reportable segment disaggregation view best depicts how the nature, amount and uncertainty of revenue and cash flows are affected by economic factors.
We record reductions in revenue for estimated price concessions granted to managed care providers. The Company considers its revenue from managed care customers to include variable consideration and estimates such amounts associated with managed care customer revenues using the history of concessions provided and cash receipts from managed care providers; we reduced our net revenue for variable consideration of $2.7 million and $3.5 million during the three months ended April 2, 2022 and April 3, 2021, respectively.
Contract Assets and Liabilities
The Company’s contract assets and contract liabilities primarily result from timing differences between the performance of our obligations and the customer’s payment.
Accounts Receivable
Credit loss expense recognized on our receivables, which is presented in SG&A expenses in the Company’s condensed consolidated statements of operations, was $0.1 million for the three months ended April 2, 2022 as compared to $0.1 million for the three months ended April 3, 2021.
Unsatisfied Performance Obligations (Contract Liabilities)
During the three months ended April 2, 2022 and April 3, 2021, we recognized $24.6 million and $20.2 million, respectively, of deferred revenues outstanding at the beginning of each respective period.
Our deferred revenue balance as of April 2, 2022 was $88.6 million. We expect future revenue recognition of this balance of $56.3 million, $23.4 million, $8.2 million, $0.6 million and $0.1 million in fiscal years 2022, 2023, 2024, 2025 and thereafter, respectively.
15

8. Leases

Our lease costs for the three months ended April 2, 2022 and April 3, 2021 were as follows:
Three Months Ended
In thousandsApril 2, 2022April 3, 2021
Operating lease cost
Fixed lease cost (a)
$21,949 $20,651 
Variable lease cost (b)
8,098 7,403 
Sublease income (c)
(875)(910)
Finance lease cost
Amortization of finance lease assets1,081 1,123 
Interest on finance lease liabilities647 780 
Net lease cost$30,900 $29,047 
(a) Includes short-term leases, which are immaterial.
(b) Includes costs for insurance, real estate taxes and common area maintenance expenses, which are variable, as are lease costs above minimum thresholds for Fred Meyer stores and lease costs for Military stores.
(c) Income from sub-leasing of stores includes rental income from leasing space to independent optometrists.
Lease Term and Discount RateAs of
April 2, 2022
As of
January 1, 2022
Weighted average remaining lease term (months)
Operating leases7676
Finance leases7072
Weighted average discount rate (a)
Operating leases4.5 %4.5 %
Finance leases (b)
11.5 %11.7 %
(a) The discount rate used to determine the lease assets and lease liabilities was derived upon considering (i) incremental borrowing rates on our term loan and revolving credit facility; (ii) fixed rates on interest rate swaps; (iii) LIBOR margins for issuers of similar credit rating; and (iv) effect of collateralization. As a majority of our leases are five-year and 10-year leases, we determined a lease discount rate for such tenors and determined this discount rate is reasonable for leases that were entered into during the period.
(b) The discount rate on finance leases is higher than operating leases because the present value of minimum lease payments was higher than the fair value of leased properties for certain leases entered into prior to adoption of ASC 842. The discount rate differential for those leases is not material to our results of operations.
In thousandsThree Months Ended
Other Information April 2, 2022April 3, 2021
Operating cash outflows - operating leases$23,409 $21,914 
Right of use assets acquired under finance leases$ $ 
Right of use assets acquired under operating leases$27,461 $23,726 
16

The following table summarizes the maturity of our lease liabilities as of April 2, 2022:
In thousands
Operating Leases (a)
Finance Leases (b)
Fiscal Year
2022$56,666 $4,857 
202388,456 6,263 
202477,419 4,734 
202572,655 4,888 
202655,137 4,496 
Thereafter124,192 6,888 
Total lease liabilities474,525 32,126 
Less: Interest63,056 6,945 
Present value of lease liabilities (c)
$411,469 $25,181 
(a) Operating lease payments include $44.5 million related to options to extend lease terms that are reasonably certain of being exercised.
(b) Finance lease payments include $1.7 million related to options to extend lease terms that are reasonably certain of being exercised.
(c) The present value of lease liabilities excludes $19.9 million of legally binding minimum lease payments for leases signed but not yet commenced.

9. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is involved in various legal proceedings incidental to its business. Because of the nature and inherent uncertainties of litigation, we cannot predict with certainty the ultimate resolution of these actions and, should the outcome of these actions be unfavorable, the Company’s business, financial position, results of operations or cash flows could be materially and adversely affected.
The Company reviews the status of its legal proceedings and records a provision for a liability when it is considered probable that both a liability has been incurred and the amount of the loss can be reasonably estimated. This review is updated periodically as additional information becomes available. If either or both of the criteria are not met, we reassess whether there is at least a reasonable possibility that a loss, or additional losses, may be incurred. If there is a reasonable possibility that a loss may be incurred, we disclose the estimate of the amount of the loss or range of losses, or that an estimate of loss cannot be made. The Company expenses its legal fees as incurred.
We are currently and may in the future become subject to various claims and pending or threatened lawsuits in the ordinary course of our business.

10. Segment Reporting

The Company provides its principal products and services through two reportable segments: Owned & Host and Legacy. The “Corporate/Other” category includes the results of operations of our other operating segments, AC Lens and FirstSight, as well as corporate overhead support. The “Reconciliations” category represents other adjustments to reportable segment results necessary for the presentation of consolidated financial results in accordance with U.S. GAAP for the two reportable segments. Incremental expenses related to the COVID-19 pandemic are allocated to the reportable segments.
Our reportable segment profit measure is earnings before interest, tax, depreciation and amortization (“EBITDA”) or net revenue, less costs applicable to revenue, less SG&A expenses. Depreciation and amortization, asset impairment, and other corporate costs that are not allocated to the reportable segments, including interest expense (income) are excluded from segment EBITDA. There are no revenue transactions between our reportable segments. There are no differences between the measurement of our reportable segments’ assets and consolidated assets. There have been no changes from prior periods in the measurement methods used to determine reportable segment profit or loss, and there have been no asymmetrical allocations to segments.
The following is a summary of certain financial data for each of our segments. Reportable segment information is presented on the same basis as our consolidated financial statements, except for net revenue and associated costs applicable to revenue, which are presented on a cash basis, including point of sales for managed care payors and excluding the effects of unearned and deferred revenue, consistent with what the Chief Operating Decision Maker (“CODM”) regularly reviews.
17

Asset information is not included in the following summary since the CODM does not regularly review such information for the reportable segments.

Three Months Ended April 2, 2022
In thousandsOwned & HostLegacyCorporate/OtherReconciliationsTotal
Net product sales$357,904 $27,630 $61,697 $(13,978)$433,253 
Net sales of services and plans80,015 14,528  (85)94,458 
Total net revenue437,919 42,158 61,697 (14,063)527,711 
Costs of products101,040 12,907 53,465 (3,193)164,219 
Costs of services and plans65,601 6,217   71,818 
Total costs applicable to revenue166,641 19,124 53,465 (3,193)236,037 
SG&A157,461 15,106 55,987  228,554 
Asset impairment   406  406 
Other expense, net  231  231 
EBITDA$113,817 $7,928 $(48,392)$(10,870)
Depreciation and amortization25,151 
Interest expense (income), net(4,144)
Earnings before income taxes$41,476 
Three Months Ended April 3, 2021
In thousandsOwned & HostLegacyCorporate/OtherReconciliationsTotal
Net product sales$369,370 $27,420 $61,218 $(14,941)$443,067 
Net sales of services and plans83,077 16,162  (8,126)91,113 
Total net revenue452,447 43,582 61,218 (23,067)534,180 
Costs of products97,104 12,859 53,026 (3,298)159,691 
Costs of services and plans58,804 6,195   64,999 
Total costs applicable to revenue155,908 19,054 53,026 (3,298)224,690 
SG&A149,963 14,293 59,337  223,593 
Asset impairment  959  959 
Other expense (income), net  (65) (65)
EBITDA$146,576 $10,235 $(52,039)$(19,769)
Depreciation and amortization23,555 
Interest expense (income), net6,330 
Earnings before income taxes$55,118 
18


11. Earnings Per Share

Diluted EPS related to the 2025 Notes is calculated using the if-converted method; the number of dilutive shares is based on the initial conversion rate associated with the 2025 Notes. A reconciliation of the numerators and denominators of the basic and diluted EPS calculations is as follows:
Three Months Ended
In thousands, except EPS April 2, 2022April 3, 2021
Net income$30,147 $43,432 
After-tax interest expense for 2025 Notes2,345 2,332 
Numerator for diluted EPS$32,492 $45,764 
Weighted average shares outstanding for basic EPS81,428 81,333 
Effect of dilutive securities:
Stock options229 1,397 
Restricted stock 336 383 
2025 Notes12,911 12,912 
Weighted average shares outstanding for diluted EPS94,904 96,025 
Basic EPS$0.37 $0.53 
Diluted EPS$0.34 $0.48 
Anti-dilutive options and RSUs outstanding excluded from EPS214 38 

12. Accumulated Other Comprehensive Loss

Changes in the fair value of the Company’s cash flow hedge derivative instruments from their inception are recorded in AOCL if the instruments are deemed to be highly effective as cash flow hedges. The following table presents the changes in AOCL, net of tax during the three months ended April 2, 2022 and April 3, 2021, respectively:
Three Months Ended
In thousandsApril 2, 2022April 3, 2021
Cash flow hedging activity:
Balance at beginning of period$(1,940)$(4,400)
Other comprehensive income (loss) before reclassification (10)
Tax effect of other comprehensive income (loss) before reclassification 3 
Amount reclassified from AOCL into interest expense252 1,660 
Tax effect of amount reclassified from AOCL into interest expense(64)(424)
Stranded tax effect of matured interest rate swaps (2,125)
Net current period other comprehensive income (loss), net of tax188 (896)
Balance at end of period$(1,752)$(5,296)
See Note 5. “Interest Rate Derivatives” for a description of the Company’s use of cash flow hedging derivatives.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following contains management’s discussion and analysis of our financial condition and results of operations and should be read together with the unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Form 10-Q (this “Form 10-Q”) and the audited consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on January 1, 2022 (the “2021 Annual Report on Form 10-K.”) This discussion contains forward-looking statements that reflect our plans, estimates and beliefs and involve numerous risks and uncertainties, including, but not limited to, those described in the “Risk Factors” section of the 2021 Annual Report on Form 10-K and in the “Risk Factors” section of this Form 10-Q, as such risk factors may be updated from time to time in our periodic filings with the SEC. Actual results may differ materially from those contained in any forward-looking statements. You should carefully read “Special Note Regarding Forward-Looking Statements” in this Form 10-Q.
Overview    
We are one of the largest and fastest growing optical retailers in the United States and a leader in the attractive value segment of the U.S. optical retail industry. We believe that vision is central to quality of life and that people deserve to see their best to live their best, regardless of their budget. Our mission is to make quality eye care and eyewear affordable and accessible to all Americans. We achieve this by providing eye exams, eyeglasses and contact lenses to value seeking and lower income consumers. We deliver exceptional value and convenience to our customers, with an opening price point that strives to be among the lowest in the industry, enabled by our low-cost operating platform. We reach our customers through a diverse portfolio of 1,292 retail stores across five brands and 18 consumer websites as of April 2, 2022.
COVID-19
The COVID-19 pandemic continued to cause business impacts in the first quarter of 2022 primarily driven by the emergence of the Omicron variant in late 2021, and its further spread in early 2022, which caused a surge in COVID-19 cases globally, and resulted in increased associate and vision care professional absences, adjusted work schedules and reduced consumer traffic for our operations.
The ultimate impact of COVID-19 on our operations and financial performance in future periods remains uncertain and will depend on future pandemic-related developments, including the duration of the pandemic, potential subsequent waves of COVID-19 infection or potential new variants, the effectiveness and adoption of COVID-19 vaccines and therapeutics, supplier impacts and related government actions to prevent and manage disease spread, including the implementation of any federal, state, local or foreign vaccine mandates, all of which are uncertain and cannot be predicted. In addition, we could experience disruptions of product deliveries as a result of supply chain issues caused by the COVID-19 pandemic, including as a result of the temporary shutdowns in countries which support our supply chain. Prolonged periods of shutdown in these countries or a deterioration of conditions in other countries that are part of our supply chain as well as increasing strains on international and domestic supply chain infrastructure could result in product and equipment availability delays, as well as increased costs to obtain and ship these items to meet customer demand. We have made, and may continue to make, inventory forward buys to help manage potential supply chain disruptions. We continue to monitor and evaluate additional measures that we may elect to take as a response to the COVID-19 pandemic and the several macroeconomic effects resulting from the pandemic. There can be no assurance whether or when any such measures will be adopted. For a discussion of measures we have previously taken in response to the pandemic, and the impact of the COVID-19 pandemic on our operations and performance, please see Part I. Item 1A. “Risk Factors” and Part II. Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s 2021 Annual Report on Form 10-K.
Overall economic condition
Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, the conflict in Ukraine, and steps taken by governments and central banks in response to the pandemic as well as other stimulus and spending programs, have led to higher inflation than previously experienced or expected. Consumer preferences and demand, as well as spending habits, including for our goods and services, are impacted by the prevailing macroeconomic conditions, inflation, salaries and wages, consumer confidence and consumer perception.
Business Impact
The COVID-19 pandemic, increasing macroeconomic uncertainty of the U.S. economy and emerging constraints to exam capacity adversely affected our sales in the first quarter of 2022 and may continue to impact our performance going forward. Early in the first quarter of 2022, the Omicron variant led to reduced customer demand and constrained the exam capacity of vision care professionals due to labor shortages in an already competitive market
20

for vision care professionals and preferences for adjusted work schedules. Exam capacity, which encompasses the overall availability of vision care professionals, is impacted by several factors including retention, hiring, remote medicine coverage and work schedules. During the quarter, adverse macroeconomic conditions such as inflation also impacted consumer demand and created a temporary challenging environment for our business. We remain focused on our strategy to provide our customers and patients reliable and quality low cost eye care and eyewear, and are taking certain actions to enhance our exam capacity through recruitment, retention and remote medicine initiatives.
The disclosures contained in this Form 10-Q are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law. For further information, please see “Forward-Looking Statements.”
Brand and Segment Information
Our operations consist of two reportable segments:
Owned & Host - As of April 2, 2022, our owned brands consisted of 852 America’s Best Contacts and Eyeglasses retail stores and 127 Eyeglass World retail stores. In America’s Best stores, vision care services are provided by optometrists employed by us or by independent professional corporations or similar entities. America’s Best stores are primarily located in high-traffic strip centers next to value-focused retailers. Eyeglass World locations primarily feature eye care services provided by independent optometrists and optometrists employed by independent professional corporations or similar entities and on-site optical laboratories that enable stores to quickly fulfill many customer orders and make repairs on site. Eyeglass World stores are primarily located in freestanding or in-line locations near high-foot-traffic shopping centers. Our Host brands consisted of 54 Vista Optical locations on select military bases and 29 Vista Optical locations within select Fred Meyer stores as of April 2, 2022. We have strong, long-standing relationships with our Host partners and have maintained each partnership for over 22 years. These brands provide eye exams primarily by independent optometrists. All brands utilize our centralized laboratories. This segment also includes sales from our America’s Best, Eyeglass World, and Military omni-channel websites.
Legacy - We manage the operations of, and supply inventory and laboratory processing services to, 230 Vision Centers in Walmart retail locations as of April 2, 2022. This strategic relationship with Walmart is in its 32nd year. Pursuant to a January 2020 amendment to our management & services agreement with Walmart, we added five additional Vision Centers in Walmart stores in fiscal year 2020. On July 17, 2020, NVI and Walmart extended the current term and economics of the management & services agreement by three years to February 23, 2024. Under the management & services agreement, our responsibilities include ordering and maintaining merchandise inventory; arranging the provision of optometry services; providing managers and staff at each location; training personnel; providing sales receipts to customers; maintaining necessary insurance; obtaining and holding required licenses, permits and accreditations; owning and maintaining store furniture, fixtures and equipment; and developing annual operating budgets and reporting. We earn management fees as a result of providing such services and therefore we record revenue related to sales of products and product protection plans to our Legacy partner’s customers on a net basis. Our management & services agreement also allows our Legacy partner to collect penalties if the Vision Centers do not generate a requisite amount of revenues. No such penalties have been assessed under our current arrangement, which began in 2012. We also sell to our Legacy partner merchandise that is stocked in retail locations we manage pursuant to a separate supplier agreement, and provide centralized laboratory services for the finished eyeglasses for our Legacy partner’s customers in stores that we manage. We lease space from Walmart within or adjacent to each of the locations we manage and use this space for vision care services provided by independent optometrists or optometrists employed by us or by independent professional corporations or similar entities. During the three months ended April 2, 2022, sales associated with this arrangement represented 8.0% of consolidated net revenue. This exposes us to concentration of customer risk.

21

Our consolidated results also include the following activity recorded in our Corporate/Other category:
Our e-commerce platform of 14 dedicated websites managed by AC Lens. Our e-commerce business consists of five proprietary branded websites, including aclens.com, discountglasses.com and discountcontactlenses.com, and nine third-party websites with established retailers, such as Walmart, Sam’s Club and Giant Eagle as well as mid-sized vision insurance providers. AC Lens handles site management, customer relationship management and order fulfillment and also sells a wide variety of contact lenses, eyeglasses and eye care accessories.
AC Lens also distributes contact lenses wholesale to Walmart and Sam’s Club. We incur costs at a higher percentage of sales than other product categories. AC Lens sales associated with Walmart and Sam’s Club contact lenses distribution arrangements represented 6.7% of consolidated net revenue.
Managed care business conducted by FirstSight, our wholly-owned subsidiary that is licensed as a single-service health plan under California law, which arranges for the provision of optometric services at the offices next to certain Walmart stores throughout California, and also issues individual vision plans in connection with our America’s Best operations in California.
Unallocated corporate overhead expenses, which are a component of selling, general and administrative expenses and are comprised of various home office expenses such as payroll, occupancy costs, and consulting and professional fees. Corporate overhead expenses also include field services for our five retail brands.
Reportable segment information is presented on the same basis as our condensed consolidated financial statements, except reportable segment sales which are presented on a cash basis including point of sales for managed care payors and excluding the effects of unearned and deferred revenue, consistent with what our CODM regularly reviews. Reconciliations of segment results to consolidated results include financial information necessary to adjust reportable segment revenues to a consolidated basis in accordance with U.S. GAAP, specifically the change in unearned and deferred revenues during the period. There are no revenue transactions between reportable segments, and there are no other items in the reconciliations other than the effects of unearned and deferred revenue. See Note 10. “Segment Reporting” in our condensed consolidated financial statements included in Part I. Item 1. of this Form 10-Q.
Deferred revenue represents the timing difference of when we collect the cash from the customer and when services related to product protection plans and eye care club memberships are performed. Increases or decreases in deferred revenue during the reporting period represent cash collections in excess of or below the recognition of previous deferrals. Unearned revenue represents the timing difference of when we collect cash from the customer and delivery/customer acceptance, and includes sales of prescription eyewear during approximately the last seven to 10 days of the reporting period.
Trends and Other Factors Affecting Our Business
Various trends and other factors will affect or have affected our operating results, including:
Impact of COVID-19
The COVID-19 pandemic has had far-reaching impacts, directly and indirectly, on our operations. We continue to monitor the evolving situation as there remain many uncertainties regarding the pandemic and more recent outbreaks of variants, including anticipated duration, vision care professional availability, related healthcare authority guidelines and efficacy of vaccination initiatives, including the impact of, and associated risks regarding, federal, state and local vaccination and testing programs. We continue to monitor potential impacts on our stores and exam capacity, lab network, and potential disruptions of product and equipment deliveries. To date, we have been able to meet customer demand with operations at our laboratories and our supply chain partners. However, prolonged shutdowns in countries which support our supply chain or a deterioration of conditions in such countries and others or increasing strains on international and domestic supply chain infrastructure could result in product and equipment availability delays in the future. We could experience further material impacts as a result of COVID-19, including, but not limited to, charges from additional asset impairments and deferred tax valuation allowances. We will continue to evaluate additional measures that we may elect to take as a response to the pandemic, including, where appropriate, future action to reduce store hours and patient appointments, temporarily close stores or make additional forward buys. There can be no assurance whether or when any such measures will be adopted. For a discussion of significant risks that have the potential to cause our actual results to differ materially from our expectations, refer to Part II. Item 1A. “Risk Factors” in this Form 10-Q and Part I. Item 1A. “Risk Factors,” included in our 2021 Annual Report on Form 10-K.

22

Overall economic trends, consumer preferences and demand
Our business depends on consumer demand for our products and, consequently, is sensitive to a number of factors that influence consumer confidence and spending, such as general economic conditions, consumer disposable income, energy and fuel prices, recession and fears of recession, unemployment, minimum wages, availability of consumer credit, consumer debt levels, conditions in the housing market, interest rates, tax rates and policies, inflation, consumer confidence in future economic conditions and political conditions, war and fears of war (including the recent Russian invasion of Ukraine), inclement weather, natural disasters, terrorism, outbreak of viruses or widespread illness and consumer perceptions of personal well-being and security. Over the past few years, global markets and economic conditions have been challenging, particularly in light of the COVID-19 pandemic. During periods of economic downturn and uncertainty, our customers especially benefit from our low prices. The long-term effects of the COVID-19 pandemic and other macroeconomic and geopolitical events on consumer preferences and demand remain uncertain. We believe, but cannot be certain, our business model of providing exceptional value and convenience to customers, enabled by our low-cost operating platform will mitigate these impacts to a certain extent; however uncertainties and risk exposures may be exacerbated by the immediate and ongoing impacts of these factors.
Vision care professional recruitment, coverage, and expanded offerings
Our ability to continue to attract and retain qualified vision care professionals affect exam capacity and is critical to our operations. Our operations, like those of many of our competitors, depend on our ability to offer both eyewear and eye exams. We compete with other optical retail companies, health systems and group practices for vision care professionals. We, as well as the professional corporations or similar entities that employ optometrists in certain of our retail locations, could face difficulties attracting and retaining qualified professionals if we or such corporations fail to offer competitive compensation and benefits. Increased compensation for vision care professionals could raise our costs and negatively affect our margins. We believe the impacts of the COVID-19 pandemic on vision care professional availability, including a competitive recruiting market and preferences for adjusted work schedules, and the demand for optometrists exceeding supply in certain areas in the first quarter of 2022 have caused constraints in exam capacity. Due to these factors the costs to employ or retain optometrists may increase, potentially materially, from current levels. We are investing in recruitment and retention initiatives along with continuing our implementation of remote medicine technologies.
Pricing strategy
We are committed to providing our products to our customers at low prices. We generally employ a simple low price/high value strategy that consistently delivers savings to our customers without the need for extensive promotions. Inflationary pressures, including wage investments, consumer confidence and preferences and increased raw material costs, could impact our profitability and lead us to attempt to offset such increases through various pricing actions. Effective May 9, 2022 we changed the price of our America’s Best signature offer to “two pairs of eyeglasses for $79.95, including a free eye exam” from its original $69.95 price. Effective March 14, 2022, we changed the price of our Eyeglass World opening offer to “two pairs of eyeglasses for $89” from its original price of $78. We believe that this change will enable us to continue to offer the best possible value and service to our customers at prices that allow us to maintain our brands’ strong value propositions in the marketplace.
Comparable store sales growth
Comparable store sales growth is a key driver of our business and our value proposition will continue to drive comparable store sales growth as we attract new customers and increase loyalty with existing customers. During the three months ended April 2, 2022 comparable store sales growth was negatively impacted due to the Omicron COVID-19 variant, constraints on exam capacity and other overall economic trends impacting consumer preferences and demand. We believe our business model of providing exceptional value and convenience to customers, enabled by our low-cost operating platform will mitigate these impacts to a certain extent. Our strategies to mitigate these effects include, but are not limited to, investing in recruitment and retention initiatives along with continuing our implementation of remote medicine technologies and optimizing our marketing investments. The impact of the COVID-19 pandemic, constraints on exam capacity and macroeconomic factors on our comparable store sales growth remains uncertain, and effects and relevant risk exposures may be exacerbated in the future.
Interim results and seasonality
Historically, our business has realized a higher portion of net revenue, operating income, and cash flows from operations in the first half of the fiscal year, and a lower portion of net revenue, operating income, and cash flows from operations in the fourth fiscal quarter. Consumer behavior driven by the COVID-19 pandemic, impacts on overall economic trends, consumer preferences and demand has resulted in a departure from seasonal norms we
23

have experienced in recent years and we expect it will continue to disrupt the historical quarterly cadence of our results of operations for an unknown period of time.
Other factors
We remain committed to our long-term vision and continue to position ourselves to make progress against our key initiatives while balancing the near-term challenges and uncertainty presented by the COVID-19 pandemic and other macroeconomic factors. We believe the following factors may continue to influence our short-term and long-term results:
New store openings;
Managed care and insurance;
Inflation;
Infrastructure investment;
Our ability to source and distribute products effectively; and
Industry competition and consolidation
How We Assess the Performance of Our Business
We consider a variety of financial and operating measures in assessing the performance of our business. The key measures we use to determine how our consolidated business and operating segments are performing are net revenue, costs applicable to revenue, and selling, general, and administrative expenses. In addition, we also review store growth, Adjusted Comparable Store Sales Growth, Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS.
Net Revenue
We report as net revenue amounts generated in transactions with retail customers who are the end users of our products, services, and plans. Comparable store sales growth and new store openings are key drivers of net revenue and are discussed below. Also, the timing of unearned revenue can affect revenue recognized in a particular period.
Costs Applicable to Revenue
Customer tastes and preferences, product mix, changes in technology, significant increases or slowdowns in production, and other factors impact costs applicable to revenue. The components of our costs applicable to revenue may not be comparable to other retailers.
Selling, General and Administrative
SG&A generally fluctuates consistently with revenue due to the variable store, field office and corporate support costs; however, some fixed costs slightly improve as a percentage of net revenue as our net revenues grow over time.
New Store Openings
The total number of new stores per year and the timing of store openings has, and will continue to have, an impact on our results. We expect to open at least 80 stores in the current year. We will continue to monitor and determine our plans for future new store openings based on health, safety and economic conditions.
24

Adjusted Comparable Store Sales Growth
We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows: (i) sales are recorded on a cash basis (i.e., when the order is placed and paid for or submitted to a managed care payor, compared to when the order is delivered), utilizing cash basis point of sale information from stores; (ii) stores are added to the calculation during the 13th full fiscal month following the store’s opening; (iii) closed stores are removed from the calculation for time periods that are not comparable; (iv) sales from partial months of operation are excluded when stores do not open or close on the first day of the month; and (v) when applicable, we adjust for the effect of the 53rd week. Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period. When a partial month is excluded from the calculation, the corresponding month in the subsequent period is also excluded from the calculation. There may be variations in the way in which some of our competitors and other retailers calculate comparable store sales. As a result, our adjusted comparable store sales may not be comparable to similar data made available by other retailers.
Adjusted Comparable Store Sales Growth is a non-GAAP financial measure, which we believe is useful because it provides timely and accurate information relating to the two core metrics of retail sales: number of transactions and value of transactions. We use Adjusted Comparable Store Sales Growth as the basis for key operating decisions, such as allocation of advertising to particular markets and implementation of special marketing programs. Accordingly, we believe that Adjusted Comparable Store Sales Growth provides timely and accurate information relating to the operational health and overall performance of each brand. We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Stores Sales Growth to be meaningful.
Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS (collectively, the “Company Non-GAAP Measures”)
The Company Non-GAAP Measures are key measures used by management to assess our financial performance. The Company Non-GAAP Measures are also frequently used by analysts, investors and other interested parties. We use the Company Non-GAAP Measures to supplement U.S. GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. See “Non-GAAP Financial Measures” for definitions of the Company Non-GAAP Measures and for additional information.
25